-
My Account
In App
My Account
BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Oct 28, 15:31Prev. Close
128.50
Open Price
128.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Sotac Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 11.05 | 11.05 | 8.05 | 2.30 | 2.30 | |
| Total Share Capital | 11.05 | 11.05 | 8.05 | 2.30 | 2.30 | |
| Reserves and Surplus | 41.98 | 37.22 | 3.47 | 4.32 | 1.92 | |
| Total Reserves and Surplus | 41.98 | 37.22 | 3.47 | 4.32 | 1.92 | |
| Total Shareholders Funds | 53.03 | 48.27 | 11.52 | 6.62 | 4.22 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 5.63 | 4.41 | 6.59 | 0.97 | 2.72 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.14 | 0.12 | 0.09 | 0.06 | 0.03 | |
| Total Non-Current Liabilities | 5.77 | 4.53 | 6.68 | 1.03 | 2.77 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 14.49 | 6.76 | 4.06 | 6.42 | 3.96 | |
| Trade Payables | 9.33 | 14.75 | 18.20 | 19.74 | 10.31 | |
| Other Current Liabilities | 1.46 | 1.00 | 2.86 | 0.26 | 0.25 | |
| Short Term Provisions | 1.21 | 0.77 | 1.99 | 1.18 | 0.39 | |
| Total Current Liabilities | 26.49 | 23.28 | 27.11 | 27.61 | 14.91 | |
| Total Capital And Liabilities | 85.29 | 76.09 | 54.78 | 35.25 | 21.91 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 16.64 | 17.65 | 14.09 | 8.79 | 6.42 | |
| Intangible Assets | 0.02 | 0.01 | 0.00 | 0.01 | 0.00 | |
| Capital Work-In-Progress | 0.20 | 0.05 | 0.04 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 16.86 | 17.72 | 14.13 | 8.80 | 6.42 | |
| Non-Current Investments | 13.33 | 11.50 | 4.00 | 0.39 | 2.17 | |
| Deferred Tax Assets [Net] | 0.20 | 0.13 | 0.04 | 0.02 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.16 | 0.16 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 30.40 | 29.34 | 18.18 | 9.38 | 8.75 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | |
| Inventories | 10.18 | 11.02 | 9.58 | 5.39 | 3.80 | |
| Trade Receivables | 24.68 | 22.01 | 11.50 | 12.25 | 5.98 | |
| Cash And Cash Equivalents | 0.45 | 0.64 | 9.60 | 0.03 | 0.02 | |
| Short Term Loans And Advances | 12.33 | 7.17 | 0.01 | 2.67 | 0.13 | |
| OtherCurrentAssets | 7.27 | 5.90 | 5.92 | 5.53 | 3.05 | |
| Total Current Assets | 54.90 | 46.75 | 36.61 | 25.88 | 13.15 | |
| Total Assets | 85.29 | 76.09 | 54.78 | 35.25 | 21.91 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.40 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | 0.02 | 0.12 | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | 11.50 | 4.00 | 0.39 | 2.17 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | 0.17 |
30.10.2024
Sotac Pharma Consolidated September 2024 Net Sales at Rs 27.35 crore, up 2.52% Y-o-Y
27.08.2024
Sotac Pharma Consolidated June 2024 Net Sales at Rs 25.25 crore, up 1.13% Y-o-Y
19.08.2024
Sotac Pharma Standalone June 2024 Net Sales at Rs 13.01 crore, down 31.18% Y-o-Y
18.06.2024
Sotac Pharma Consolidated March 2024 Net Sales at Rs 26.45 crore, up 46.24% Y-o-Y
30.10.2024
Sotac Pharma Consolidated September 2024 Net Sales at Rs 27.35 crore, up 2.52% Y-o-Y
27.08.2024
Sotac Pharma Consolidated June 2024 Net Sales at Rs 25.25 crore, up 1.13% Y-o-Y
19.08.2024
Sotac Pharma Standalone June 2024 Net Sales at Rs 13.01 crore, down 31.18% Y-o-Y
18.06.2024
Sotac Pharma Consolidated March 2024 Net Sales at Rs 26.45 crore, up 46.24% Y-o-Y
